| 1 | regulation of penile erection (GO:0060405) | 9.65587231 |
| 2 | short-term memory (GO:0007614) | 9.61023947 |
| 3 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 9.41652629 |
| 4 | specification of organ identity (GO:0010092) | 8.36376184 |
| 5 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 8.20556037 |
| 6 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 8.20556037 |
| 7 | behavioral response to ethanol (GO:0048149) | 7.93145385 |
| 8 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 7.90205472 |
| 9 | oxygen transport (GO:0015671) | 7.83214896 |
| 10 | prenylation (GO:0097354) | 7.80912501 |
| 11 | protein prenylation (GO:0018342) | 7.80912501 |
| 12 | adaptation of signaling pathway (GO:0023058) | 7.27066268 |
| 13 | hindbrain development (GO:0030902) | 7.25337723 |
| 14 | response to histamine (GO:0034776) | 6.84559862 |
| 15 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 6.69556098 |
| 16 | chemosensory behavior (GO:0007635) | 6.57862083 |
| 17 | mitochondrion localization (GO:0051646) | 6.38846387 |
| 18 | gas transport (GO:0015669) | 6.11851456 |
| 19 | behavioral response to cocaine (GO:0048148) | 6.10468217 |
| 20 | regulation of neurotransmitter uptake (GO:0051580) | 6.07590111 |
| 21 | synaptic transmission, dopaminergic (GO:0001963) | 5.91068275 |
| 22 | arachidonic acid secretion (GO:0050482) | 5.87927534 |
| 23 | icosanoid secretion (GO:0032309) | 5.87927534 |
| 24 | regulation of voltage-gated calcium channel activity (GO:1901385) | 5.57130100 |
| 25 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 5.28061546 |
| 26 | cellular response to zinc ion (GO:0071294) | 4.99680073 |
| 27 | regulation of proton transport (GO:0010155) | 4.98403609 |
| 28 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.96461572 |
| 29 | mitochondrion transport along microtubule (GO:0047497) | 4.96461572 |
| 30 | positive regulation of cell size (GO:0045793) | 4.89368840 |
| 31 | regulation of catecholamine metabolic process (GO:0042069) | 4.88958634 |
| 32 | regulation of dopamine metabolic process (GO:0042053) | 4.88958634 |
| 33 | positive regulation of RNA splicing (GO:0033120) | 4.76514988 |
| 34 | icosanoid transport (GO:0071715) | 4.65465206 |
| 35 | fatty acid derivative transport (GO:1901571) | 4.65465206 |
| 36 | RNA destabilization (GO:0050779) | 4.57940552 |
| 37 | establishment of mitochondrion localization (GO:0051654) | 4.52153940 |
| 38 | positive regulation of mRNA processing (GO:0050685) | 4.51119721 |
| 39 | retina development in camera-type eye (GO:0060041) | 4.35386666 |
| 40 | negative regulation of cation channel activity (GO:2001258) | 4.35103324 |
| 41 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 4.31250283 |
| 42 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 4.31250283 |
| 43 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 4.30935380 |
| 44 | cellular response to cadmium ion (GO:0071276) | 4.22752743 |
| 45 | positive regulation of neurotransmitter transport (GO:0051590) | 4.04993937 |
| 46 | positive regulation of amine transport (GO:0051954) | 3.99551148 |
| 47 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.96109135 |
| 48 | multicellular organism reproduction (GO:0032504) | 3.94100355 |
| 49 | base-excision repair, AP site formation (GO:0006285) | 3.94082163 |
| 50 | bicarbonate transport (GO:0015701) | 3.89321240 |
| 51 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.84653812 |
| 52 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.83493054 |
| 53 | positive regulation of protein deacetylation (GO:0090312) | 3.71427489 |
| 54 | positive regulation of microtubule polymerization (GO:0031116) | 3.67762725 |
| 55 | membrane hyperpolarization (GO:0060081) | 3.66635050 |
| 56 | regulation of systemic arterial blood pressure (GO:0003073) | 3.66273278 |
| 57 | positive regulation of mRNA metabolic process (GO:1903313) | 3.63631804 |
| 58 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.61776296 |
| 59 | negative regulation of adenylate cyclase activity (GO:0007194) | 3.58525306 |
| 60 | negative regulation of cAMP biosynthetic process (GO:0030818) | 3.55479022 |
| 61 | dopamine receptor signaling pathway (GO:0007212) | 3.52853686 |
| 62 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 3.51549493 |
| 63 | behavioral fear response (GO:0001662) | 3.50916856 |
| 64 | behavioral defense response (GO:0002209) | 3.50916856 |
| 65 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.50319492 |
| 66 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.47774927 |
| 67 | regulation of monocyte differentiation (GO:0045655) | 3.47272584 |
| 68 | negative regulation of JUN kinase activity (GO:0043508) | 3.43337481 |
| 69 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 3.42239888 |
| 70 | negative regulation of cyclase activity (GO:0031280) | 3.40746199 |
| 71 | response to amphetamine (GO:0001975) | 3.36474035 |
| 72 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.36182487 |
| 73 | NADH dehydrogenase complex assembly (GO:0010257) | 3.36182487 |
| 74 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.36182487 |
| 75 | negative regulation of lyase activity (GO:0051350) | 3.33348870 |
| 76 | negative regulation of cAMP metabolic process (GO:0030815) | 3.28283872 |
| 77 | nucleobase catabolic process (GO:0046113) | 3.27444992 |
| 78 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 3.25808326 |
| 79 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.25249303 |
| 80 | rhodopsin mediated signaling pathway (GO:0016056) | 3.24460408 |
| 81 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 3.19262542 |
| 82 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 3.19262542 |
| 83 | response to misfolded protein (GO:0051788) | 3.19191549 |
| 84 | negative regulation of response to food (GO:0032096) | 3.17602051 |
| 85 | negative regulation of appetite (GO:0032099) | 3.17602051 |
| 86 | negative regulation of cyclic nucleotide metabolic process (GO:0030800) | 3.16956525 |
| 87 | regulation of protein deacetylation (GO:0090311) | 3.13430549 |
| 88 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.12682890 |
| 89 | translesion synthesis (GO:0019985) | 3.10273605 |
| 90 | histone H3-K4 trimethylation (GO:0080182) | 3.05769398 |
| 91 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.02668463 |
| 92 | negative regulation of digestive system process (GO:0060457) | 2.98813913 |
| 93 | protein K11-linked deubiquitination (GO:0035871) | 2.97163399 |
| 94 | fear response (GO:0042596) | 2.94583358 |
| 95 | protein targeting to Golgi (GO:0000042) | 2.93951381 |
| 96 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.91892286 |
| 97 | regulation of calcium-mediated signaling (GO:0050848) | 2.91281854 |
| 98 | erythrocyte maturation (GO:0043249) | 2.90569889 |
| 99 | sperm capacitation (GO:0048240) | 2.90406558 |
| 100 | mitochondrion distribution (GO:0048311) | 10.1314780 |
RPSAP57 
